BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Hematopoietic cell
,
Aspirin
,
rs7903146
,
CYP51
,
Apoptosis
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TORC1
Summary
General Info
Curated Studies
Most Correlated Studies
Hematopoeitic stem and progenitor cells: specific TORC1 knockout
Hematopoietic progenitor cells with induced RPTOR-knockout
S. pombe cells with isp7+ knockout
S. cerevisiae exponential cultures; nitrogen sources shifted between proline and glutamine
S.cerevisiae gene expression under nutrient deprivation in snf1 and tor1 null strains
Explore Curated Studies Results
Literature
Most Relevant Literature
Non-dikarya fungi share the TORC1 pathway with animals, not with Saccharomyces cerevisiae.
Vacuoles provide the source membrane for TORC1-containing signaling endosomes.
The Greatwall kinase Rim15 promotes microautophagy and microlipophagy under the control of TORC1.
Curcumin Inhibits TORC1 and Prolongs the Lifespan of Cells with Mitochondrial Dysfunction.
Distinct TORC1 signalling branches regulate Adc17 proteasome assembly chaperone expression.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neov…
Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) …
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjec…
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanc…
Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ